Company / Total Assets
Aquestive Therapeutics, Inc. Total Assets History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$160.4M
FY2025
5-year range
$57.1M / $160.4M
FY2021-FY2025
Trend
+58.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has increased for 3 consecutive years, from $57M in FY2022 to $160M in FY2025.
Based on SEC 10-K filings.
$160M in FY2025 with a 5-year CAGR of +20.6%.
Improved from $57M to $160M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- +41.1%
- 5-Year CAGR
- +20.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- Aquestive Therapeutics, Inc.'s total assets has grown for 3 consecutive years.
- 5-year CAGR of +20.6%, indicating consistent growth.
- In FY2025, total assets increased 58.2% year-over-year.
- Lowest total assets in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $160.4M | +58.2% |
| FY2024 | $101.4M | +76.6% |
| FY2023 | $57.4M | +0.6% |
| FY2022 | $57.1M | -7.9% |
| FY2021 | $62.0M | -1.4% |
| FY2020 | $62.9M | -19.9% |
| FY2019 | $78.5M | -9.6% |
| FY2018 | $86.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026